Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02888626 · ClinicalTrials.gov registry record · NA
Study of a Novel Microlens Array Device for Skin Rejuvenation
A NA study, sponsored by Cutera.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02888626: Completed NA study, sponsored by Cutera.
NCT02888626 is a NA study that has completed, run by Cutera. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02888626, a NA study, has completed, sponsored by Cutera.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
A single-center prospective, open-label uncontrolled pilot study. Subjects will receive laser treatments and will be followed at 12 weeks post-final treatment.
Primary Outcome
Degree of improvement at 12 weeks post-final treatment as assessed by the Investigator. Higher scores indicate better outcomes 3= Very significant Improvement 2= Significant Improvement 1= Moderate Improvement 0= Mild or No Improvement
Interventions
- DEVICE Microlens Array
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-02-06 |
| Phase | NA |
What the finished NCT02888626 record still lists
NCT02888626 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Microlens Array is the first listed.
NCT02888626 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02888626 about?
NCT02888626 is a clinical study titled "Study of a Novel Microlens Array Device for Skin Rejuvenation". A single-center prospective, open-label uncontrolled pilot study. Subjects will receive laser treatments and will be followed at 12 weeks post-final treatment.
What is the current status of trial NCT02888626?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2016-08. Estimated completion is 2017-02-06.
What interventions are being tested in trial NCT02888626?
The interventions under investigation include: Microlens Array (DEVICE).
Who is sponsoring clinical trial NCT02888626?
This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02888626's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia